- Home /
- Live Rates /
- CRON

<% signal.analyst %>
<% signal.analyst %>
Last Updated: Apr 03, 2026 03:35:22 PM (GMT)
CRON: The current market price is 2.62, with no previous price change data available.
Support and Resistance Levels The pivot point is 2.62, with three support levels at 2.62 and three resistance levels also at 2.62.
Indicators Current RSI is 100, showing consistent overbought conditions with no historical change. ATR is 0, indicating no price volatility. The Parabolic SAR is currently at 2.62 with a static history. All moving averages (SMA/EMA) are at 2.62, reflecting horizontal trend momentum with no directional indication.
Market Sentiment Price is at the pivot of 2.62; indicators suggest a reluctant bullish scenario if momentum builds despite no volatility signals.
CRON Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (CRON) Cronos Group Inc.
Company Overview
Cronos Group Inc. (symbol: CRON) is a leading Canadian cannabis company, primarily engaged in the production and distribution of cannabis and cannabis-derived products. Established in 2013, Cronos Group has rapidly positioned itself as a prominent player within the burgeoning global cannabis market. The company operates with a commitment to innovation and high-quality product offerings, backed by advanced research and development capabilities.
Market Position
Cronos Group is recognized for its diverse portfolio of brands, including the likes of CRONOS, Lord Jones, and Peace Naturals. The company has strategically aligned itself within the market to cater to various consumer preferences, ranging from recreational to wellness-focused products. With a strong emphasis on international expansion, Cronos Group is actively seeking opportunities in emerging markets, enhancing its reach beyond Canada. The company leverages its established infrastructure to capitalize on the evolving regulatory landscape, contributing to its competitive edge in the industry.
Key Financial Highlights
Cronos Group has demonstrated notable financial growth, driven by a robust increase in demand for cannabis products. For the fiscal year, the company reported significant revenue growth, attributed to both domestic sales and international endeavors. With a strong balance sheet and strategic partnerships, including a noteworthy investment from Altria Group, Cronos is well-positioned to sustain its growth trajectory. The company continues to invest in innovation and technological advancements, aiming to optimize production efficiency and product quality.
Industry Insights
As the global cannabis market continues to expand, Cronos Group is strategically positioned to benefit from evolving consumer trends and increasing regulatory acceptance. The company’s commitment to sustainability and ethical practices resonates with consumers, enhancing its brand loyalty. Cronos is also focused on research initiatives aimed at understanding the medical benefits of cannabis, further solidifying its reputation as a pioneer within the industry.
Conclusion
With its commitment to innovation, diverse product range, and strategic market positioning, Cronos Group Inc. is poised to continue leading the way in the cannabis sector. Investors looking for opportunities in the growing cannabis market may find Cronos Group to be a compelling choice.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
